Study Stopped
Study site did not have sufficient subjects for the case group
Three Interacting Single Nucleotide Polymorphisms (SNPs) and the Risk of Preterm Birth in Black Families
Genetic Variations in Three Interacting Single Nucleotide Polymorphisms and the Risk of Preterm Birth in Black Families
1 other identifier
observational
258
1 country
2
Brief Summary
A multilocus interaction of three pro-inflammatory cytokine single nucleotide polymorphisms (SNPs), -3448 Tumor Necrosis Factor-α, -7227 Interleukin 6, and 33314 Interleukin 6R was reported by Menon and associates in 2006. The researchers reported that they were able to predict spontaneous preterm birth in 65.2% of a population restricted to European-American mothers. Expansion of this research is needed to determine if the results are also applicable in Black populations. Statement of Purpose The purpose of this research is to determine if the multi-locus genetic interaction of tumor necrosis factor-α (-3448), interleukin 6 (-7227), and interleukin 6R (33314), as described by Menon et al. (2006), is associated with preterm birth in Black mother-infant dyads. Research Aims and Hypotheses: Primary Aim 1.0: To determine if carriage of one of the high risk genetic patterns, as identified by Menon et al. (2006), is present in 65% of Black mothers with preterm births and 35% of Black mothers with term births. Hypothesis 1.0: There is no statistically significant difference in the occurrence of one of the eight high risk genetic patterns, as identified by Menon et al. (2006), in a population of Black mothers with preterm births (case) and Black mothers with term births (controls). Primary Aim 2.0: To determine if carriage of one of the high risk genetic patterns, as identified by Menon et al. (2006), is present in 65% of Black preterm newborns and 35% of Black term newborns. Hypothesis 2.0: There is no statistically significant difference in the occurrence of one of the eight high risk genetic patterns, as identified by Menon et al. (2006), in a population of Black preterm newborns (case) and Black term newborns (controls).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2008
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2008
CompletedFirst Posted
Study publicly available on registry
May 12, 2008
CompletedStudy Start
First participant enrolled
September 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedDecember 17, 2015
December 1, 2015
11 months
May 7, 2008
December 16, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine if carriage of one of the high risk genetic patterns, as identified by Menon et al. (2006), is present in 65% of Black mothers and their infants with preterm births and 35% of Black mothers and their infants with term births.
2 years
Secondary Outcomes (1)
To determine the frequency of low risk genetic patterns, as identified by Menon et al. (2006), in Black mothers and their infants with preterm births and Black mothers and their infants with term births.
2 years
Study Arms (2)
Preterm group
Preterm (36 6/7 weeks gestation or earlier) mothers and their newborns.
Term group
Term (\> 37 weeks gestation) mothers and their newborns.
Interventions
Blood spot specimens will be drawn from mother-baby dyads in the control and experimental groups and sent for genotyping
Eligibility Criteria
The study populations were preterm mothers and their infants, born prior to 37 weeks gestation, and term mothers and their infants.
You may qualify if:
- Mother and Father, if named on the birth certificate application, are English speaking.
- If mother and Father are married, husband is the man identified as the father on the birth certificate application.
- Documentation of Informed Consent for Mother and newborn. Father named on the birth certificate application must consent for newborn to participate.
- Mother's age (and Father if named on the birth certificate application) is 18 years of age or older.
- Infant is a singleton, inborn newborn.
- Newborn gestational age assessment documented in the health record between 23 weeks 0/7 days and 36 weeks 6/7 days.
- Newborn gestational age assessment documented in the health record \> 37 weeks and 0/7 days.
- Mother identifies herself as Black or African American on the birth certificate application.
You may not qualify if:
- Mother (or Father identified on the birth certificate application) refuses to sign informed consent.
- Mother (or Father identified on the birth certificate application) does not speak English.
- Father, identified on the birth certificate application, objects to infant's participation.
- Husband is not the father named on the birth certificate application.
- Mother (or Father, if named on the birth certificate application) is less than 18 years of age.
- Mother fails to identify her ethnic group as Black or African American on the birth certificate application.
- Mother is cognitively impaired as a result of receiving narcotic analgesia within four hours of the time the research is explained, consent explained, or the interview is conducted.
- Mother is documented to be cognitively impaired by her physician in the medical record.
- Father appears to be cognitively impaired at the time the research is explained, consent explained, or the interview is conducted.
- Mother or infant has a history of blood transfusion in the last six months.
- Mother had assisted reproduction.
- Maternal surgical procedures during pregnancy, to include cerclage.
- Mother has uterine abnormalities.
- History of trauma prior to the onset of labor.
- Multiple gestation.
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Miamilead
- Pediatrixcollaborator
Study Sites (2)
Broward Medical Center
Fort Lauderdale, Florida, 33312, United States
Broward General Medical Center
Fort Lauderdale, Florida, 33316, United States
Related Publications (1)
Menon R, Velez DR, Simhan H, Ryckman K, Jiang L, Thorsen P, Vogel I, Jacobsson B, Merialdi M, Williams SM, Fortunato SJ. Multilocus interactions at maternal tumor necrosis factor-alpha, tumor necrosis factor receptors, interleukin-6 and interleukin-6 receptor genes predict spontaneous preterm labor in European-American women. Am J Obstet Gynecol. 2006 Jun;194(6):1616-24. doi: 10.1016/j.ajog.2006.03.059.
PMID: 16731080BACKGROUND
Biospecimen
Blood spot specimens were collected from the mother and her infant.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gail McCain, PhD
University of Miami
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 7, 2008
First Posted
May 12, 2008
Study Start
September 1, 2008
Primary Completion
August 1, 2009
Study Completion
August 1, 2009
Last Updated
December 17, 2015
Record last verified: 2015-12